EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Attendo AB (publ) (ATT) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Attendo AB (publ) SEK 115, price SEK 129, upside -10.6%, quality 62 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · SE · ISIN SE0007666110

AA Broad data Sep 24, 2026

Attendo AB (publ)

ATT · ST

Overvalued / MonitorQuality is not strong enough to offset the price risk.

!Fair value kr 115.29 · Overvalued (−11%)
!Quality 62/100
Healthy Growth (revenue 5y +9.1 %/yr)
!Thin margins · 4.6% net margin (TTM)
Moderate debt · generates free cash flow
·0.70% dividend yield
!Mixed vs. peers (6/15)
!Moderate moat 48/100
!Insider activity 45/100
!Weak on valuation: 19 out of 100
!Weak on dividend: 14 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

kr 129.30 kr 17.67 Fair Value kr 115.29 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range kr 17.67 – kr 129.30 · fair‑value band kr 80.70 – kr 153.23 · the kr 128.90 price screens above the kr 115.29 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Sep 24, 2026.

Follow Attendo AB (publ) in your weekly email

Every Wednesday you see whether Attendo AB (publ) is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Attendo AB (publ) provides health and care services in Scandinavia and Finland.

Show more

Attendo AB (publ) provides health and care services in Scandinavia and Finland. The company offers nursing homes for people with dementia or somatic care requirements; home care services, including care, meals, cleaning, laundry, evening and night, and home health care services; and homes for people of various ages with a range of disabilities or care needs. It also provides day care, respite care and companion, meal and staffing services, as well as short term accommodation; personalized residential care for people with neuropsychiatric and psychosocial disorders; and runs family homes, crisis and emergency homes, HVB homes, dependency care, schools, and various forms of supportive housing. The company was founded in 1985 and is headquartered in Danderyd, Sweden.

Stock analysis

Attendo AB (publ) (ATT) currently trades at kr 128.90, while our model-based Fair Value estimate is kr 115.29, implying the stock looks roughly 11.8% overvalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of kr 236.07 per share, and 14 of the 24 models we run sit above the kr 128.90 price.

Bear case: the Asset-Based group reads lowest at kr 25.68, and 10 of the 24 models stay below the price. Evidence for this calculation is high.

Scenario range: kr 80.70 (bear) to kr 153.23 (bull), the price of kr 128.90 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 62/100 (solid quality), in the Healthcare sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Attendo AB (publ) reported revenue of 19.0B SEK in FY2025 versus 12.9B SEK in FY2021, a compound +10.2%/yr. Reported net income was 813M SEK in FY2025, compounding +95.2%/yr from FY2021. FY2021 was a trough year, so the rate overstates the trend.

Key figures

Market cap 19.3B SEK (≈ $2.0B) · P/E ratio 21.9 · P/S ratio 0.94 · EPS (TTM) kr 5.88 · Dividend yield 0.7% · Net margin 4.3% · Return on equity 16.4% · Return on assets (EBIT) 4.9%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).

What moves the price

The share trades at its 52-week high and 92% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 35% fair-value upside, at −11%, ATT screens richer than that median.

Fair Value models

Bear kr 80.70 Fair Value kr 115.29 Bull kr 153.23
Model Each model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (kr 3.64 per share) are deliberately not added. Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence Evidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF kr 216.16 kr 328.87 kr 484.11 80
Growth DCF kr 216.47 kr 312.45 kr 435.36 79
Owner Earnings kr 210.45 kr 320.35 kr 471.70 76
All 24 models by family
DCF Models
FCF DCF kr 216.16 kr 328.87 kr 484.11 80
Owner Earnings kr 210.45 kr 320.35 kr 471.70 76
5Y Revenue Exit kr 142.17 kr 212.75 kr 300.57 73
5Y EBITDA Exit kr 224.91 kr 370.94 kr 542.73 74
5Y P/E Exit kr 128.74 kr 187.09 kr 247.24 71
10Y Revenue Exit kr 166.89 kr 236.07 kr 326.31 67
10Y EBITDA Exit kr 218.47 kr 337.61 kr 498.61 68
10Y P/E Exit kr 161.91 kr 219.59 kr 288.37 65
Earnings-Based
Graham-Dodd kr 38.92 kr 134.88 kr 181.20 64
Lynch FV kr 31.25 kr 44.65 kr 58.04 61
PEG = 1.0 kr 31.25 kr 44.65 kr 58.04 57
EPV kr 74.03 kr 85.76 kr 95.54 74
Multiples
P/E Multiple kr 94.44 kr 125.92 kr 157.40 63
P/S Multiple kr 72.98 kr 97.30 kr 121.63 58
P/B Multiple kr 72.98 kr 97.30 kr 121.63 55
EV/EBIT kr 143.98 kr 195.98 kr 247.99 66
EV/EBITDA kr 260.52 kr 351.38 kr 442.23 67
EV/Revenue kr 99.32 kr 147.04 kr 194.76 53
Asset-Based
NCAV (Graham) kr 19.17 kr 25.68 kr 38.33 54
Growth DCF
Growth DCF kr 216.47 kr 312.45 kr 435.36 79
Rev-Margin DCF kr 142.17 kr 215.22 kr 302.66 73
Economic Profit
Residual Income kr 35.97 kr 43.89 kr 91.35 71
ROIC Compounder kr 79.73 kr 100.33 kr 123.40 72
Growth Earnings
Growth-Adj P/E kr 80.70 kr 115.29 kr 149.88 67

Open the full fair value analysis →

Notify me when ATT reaches fair value

Put ATT on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 62/100

Of which business quality 59 · Market factors (momentum, volatility) 80

Profitability 39
Margins and returns on capital today
Quality Growth 41
Are margins and returns improving?
Cashflow 79
Earnings quality: real cash, not paper profit
Fin. Strength 29
Balance sheet, leverage, solvency risk
Investment 89
Disciplined investing over empire-building
Low Volatility 64
Calm price path (market factor)
Momentum 79
Price trend over the last 3–12 months (market factor)
52W Momentum 100
Distance to the 52-week high (market factor)
Net Issuance 100
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality Growth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 84/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+0.1%
Revenue growth 3 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.4%
Revenue growth 5 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.1%
Start year 2020 (pandemic). Over 10 years: +6.8% a year
Revenue growth 14 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.1%
What shareholders gained per year (last 5 years) (mathematically smoothed) What the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
+94.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year+94.2%
Dividend (yield on the price)0.7%
Pace: 5 vs 10 years Two data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.66% vs 12%, picking up
Profit margin 2020 to 2025 Operating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−2% → 9%
2025 sits 109% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Start year 2020 (pandemic)

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes This turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−4.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Sweden: IMF forecast 2.0% a year to 2030, 2.9% from 2016 to 2025) that is about −6.3% a year for the price.

ATT screens 12% overvalued. Compare with HCA Healthcare, Inc →

Compare Attendo AB (publ) with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 257 stocks

Beats the industry median on 6/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 62 · Top 25%
Fair Value upside −11% · Below median
Profitability
Return on equity (TTM) 16% · Top 25%
Return on assets 5% · Above median
Net margin (TTM) 5% · Below median
Operating margin (TTM) 10% · Above median
Growth and dividend
Revenue growth −2% · Bottom 25%
Dividend yield (TTM) 0.7% · Bottom 25%
Balance sheet
Debt / equity 0.55× · Highest 25%

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/E (TTM) 21.9× · Pricier than median
P/B 3.55× · book value is mostly goodwill Goodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (TTM) 1.02× · Cheaper than median
P/FCF 0.7× · Cheaper than median
EV/EBITDA 9.8× · Pricier than median
PEG 1.44× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)19 · sector 33
FUTURE (revenue growth)0 · sector 29
PAST (return on equity)66 · sector 31
HEALTH (low debt)73 · sector 89
DIVIDEND (yield)14 · sector 42

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
HCA Healthcare, Inc HCA $438.12 $592.64 +35%
Fresenius SE FRE €45.57 €34.54 −24%
Dr. Sulaiman Al Habib Medical Services Group 4013 227.50 SAR 109.45 SAR −52%
IHH Healthcare Berhad, an investment holding company, 5225 8.00 MYR 4.87 MYR −39%
Tenet Healthcare Corporation THC $262.06 $399.58 +52%
DaVita Inc DVA $183.72 $255.97 +39%
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹9,069 ₹2,908 −68%
Fresenius Medical Care AG FME €39.30 €71.28 +81%
Aier Eye Hospital Group 300015 ¥8.07 ¥10.86 +35%
Encompass Health Corporation EHC $122.76 $96.51 −21%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Attendo AB (publ) Fair Value". https://www.fairvalue-calculator.com/stock/ATT

Frequently asked questions

Is Attendo AB (publ) (ATT) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of kr 115.29 versus a price of kr 128.90, about −11% upside (overvalued).
What is the fair value of ATT?
Our model-based fair value for Attendo AB (publ) is kr 115.29 (as of Sep 24, 2026), built from audited fundamentals. The current price: kr 128.90.
What is the quality score of ATT?
Attendo AB (publ) has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Attendo AB (publ) (ATT)?
Our model-based price target is the fair value of kr 115.29 (as of Sep 24, 2026) from 24 valuation models. Cautious scenario kr 80.70, optimistic scenario kr 153.23. It is a calculation from audited fundamentals, not an analyst target.
What is the Attendo AB (publ) stock forecast for 2026?
Our models put fair value at kr 115.29, about −11% upside versus a price of kr 128.90 (overvalued). Cautious scenario kr 80.70, optimistic scenario kr 153.23. The calculation is refreshed regularly with new filings.
What is the revenue of Attendo AB (publ) (ATT)?
Attendo AB (publ) reported trailing-twelve-month revenue of about 18.9B SEK (latest available figure, as of Sep 24, 2026).
Does Attendo AB (publ) pay a dividend?
Attendo AB (publ) currently shows a dividend yield of about 0.70% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Attendo AB (publ) (ATT)?
For today's price to be fair in a discounted-cash-flow model, Attendo AB (publ) would have to grow free cash flow by -4.5 % per year for five years (discount rate 11.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +9.1 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of ATT use?
Our models discount Attendo AB (publ) at 11.1 %: a base by market capitalisation (small), damped by beta 1.02, country premium for Sweden. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Attendo AB (publ) that is -4.5 % per year a year over ten years, using the same discount rate (11.1 %) and the same formula as our fair value.
How much growth has Attendo AB (publ) (ATT) delivered so far?
Over the past 5 years revenue at Attendo AB (publ) grew +9.1 % a year. The price currently implies -4.5 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Attendo AB (publ) (ATT) growing?
The median revenue growth in the sector is +4.2 % a year. That is the yardstick for the growth priced into Attendo AB (publ) (-4.5 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Attendo AB (publ) (ATT)?
The free-cash-flow yield on the price is 13.68 %: that much free cash flow Attendo AB (publ) produces per unit of market value. When it exceeds the discount rate of our models (11.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Attendo AB (publ) (ATT)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Attendo AB (publ) it is kr 115.29 per share (as of Sep 24, 2026), against a price of kr 128.90. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Attendo AB (publ) stock overvalued or undervalued in 2026?
As of Sep 24, 2026, ATT trades above its calculated fair value: price kr 128.90, fair value kr 115.29, a gap of about −11% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ATT?
No. The price is what the market pays today (kr 128.90); the fair value is what the company's own numbers justify (kr 115.29). For Attendo AB (publ) the two are kr 13.61 per share apart. That gap is exactly why we show both numbers side by side.
How much is Attendo AB (publ) worth?
The market values Attendo AB (publ) at about 19.3B SEK (market capitalisation, as of Sep 24, 2026). Per share that is kr 128.90; our models calculate a fair value of kr 115.29 per share.
What do the bullish and bearish scenarios say about ATT?
Our models span a range for Attendo AB (publ): cautious scenario kr 80.70, base kr 115.29, optimistic kr 153.23 per share (as of Sep 24, 2026, price kr 128.90). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ATT?
Attendo AB (publ) trades at a price-to-earnings ratio of 21.9 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of kr 115.29 is built from several models across several years. Other multiples: PEG 1.4, P/B 3.6, P/S 1.0, EV/EBITDA 9.8.
What is the PEG ratio of ATT?
The PEG ratio of Attendo AB (publ) is 1.44 (P/E divided by earnings growth, as of Sep 24, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Attendo AB (publ) (ATT)?
Balance-sheet figures for Attendo AB (publ) (as of Sep 24, 2026): return on equity 16.4%, debt of 0.55 per unit of equity. They feed the Quality Score of 62/100, which measures business quality independently of the share price.
How far is ATT from its 52-week high?
Attendo AB (publ) trades at kr 128.90, at its 52-week high of kr 129.30 and 92% above the low of kr 67.21 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of kr 115.29 is for.
Which stocks are comparable to Attendo AB (publ)?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, IHH Healthcare Berhad, an investment holding company,, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Attendo AB (publ) stock attractive at the current price?
The data as of Sep 24, 2026: price kr 128.90, calculated fair value kr 115.29 (−11%), Quality Score 62/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ATT calculated?
We run Attendo AB (publ) through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 115.29, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Attendo AB (publ) itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Attendo AB (publ) (ATT)?
The closing price on Sep 23, 2026 was kr 128.90. Our model-based fair value is kr 115.29, about −11% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Attendo AB (publ) right now?
A fairly wide model range (kr 80.70 to kr 153.23) leaves room in how you read the outcome. The price sits in the upper half of our model range, so the margin of safety is thin. The data supports the verdict: every model runs on fully documented inputs.
Where does the earnings growth of Attendo AB (publ) (ATT) come from?
Earnings per share at Attendo AB (publ) grew +3.8 % a year from 2014 to 2025. Broken into its drivers: revenue per share +7.7 %, EBIT margin −1.2 %, tax rate +0.5 %, residual (interest, one-offs) −2.9 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Attendo AB (publ)

How large is the market capitalisation of Attendo AB (publ) (ATT)?
The market capitalisation of Attendo AB (publ) is 19.3B SEK (≈ $2.0B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Attendo AB (publ) (ATT)?
The price-to-sales ratio of Attendo AB (publ) is 0.94 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Attendo AB (publ) (ATT)?
Earnings per share at Attendo AB (publ) are kr 5.88 (price ÷ EPS = P/E 21.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Attendo AB (publ) (ATT)?
The dividend yield of Attendo AB (publ) is 0.7% (payout 15.3%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Attendo AB (publ) (ATT)?
The net margin of Attendo AB (publ) is 4.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Attendo AB (publ) (ATT)?
The return on equity (ROE) of Attendo AB (publ) is 16.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Attendo AB (publ) (ATT)?
On an EBIT basis the return on assets of Attendo AB (publ) is 4.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Attendo AB (publ) (ATT)?
The operating margin of Attendo AB (publ) is 9.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Attendo AB (publ) (ATT)?
Revenue at Attendo AB (publ) is growing −1.6% versus a year earlier (3y avg +9.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Attendo AB (publ) (ATT)?
Earnings per share at Attendo AB (publ) are growing +52.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Attendo AB (publ) (ATT) carry?
The net debt of Attendo AB (publ) is 15.2B SEK (fiscal year 2025, ≈ 5.7 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Attendo AB (publ) in the live analysis

One click puts Attendo AB (publ) on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.